Gleevec and Ear buzzing - a phase IV clinical study of FDA data

Summary:

Ear buzzing is reported as a side effect among people who take Gleevec (imatinib mesylate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Protonix, and have Gastrointestinal stromal tumor.

The phase IV clinical study analyzes which people have Ear buzzing when taking Gleevec. It is created by eHealthMe based on reports of 35,000 people who have side effects when taking Gleevec from the FDA, and is updated regularly.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

What is Ear buzzing?

Ear buzzing is found to be associated with 2,384 drugs and 3,083 conditions by eHealthMe. Check the latest studies of Ear buzzing.

On Dec, 07, 2025

35,000 people reported to have side effects when taking Gleevec.
Among them, 57 people (0.16%) have Ear buzzing.

Among these 57 people:

* Approximation only. Some reports may have incomplete information.

Do you take Gleevec and have Ear buzzing?

- Check whether Ear buzzing is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gleevec:

Gleevec (35,415 reports)

Ear buzzing treatments and more:

Ear buzzing (58,543 reports)

How severe was Ear buzzing and when was it recovered:

Ear buzzing in Gleevec

Expand to all the drugs that have ingredients of imatinib mesylate:

Ear buzzing and drugs with ingredients of imatinib mesylate (183 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Common Gleevec side effects:

Gleevec side effect: Nausea (feeling of having an urge to vomit) (2,983 reports)
Gleevec side effect: Fatigue (feeling of tiredness) (2,050 reports)

Browse all side effects of Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Ear buzzing:

Browse all the drugs that are associated with Ear buzzing:

Ear buzzing (2,384 drugs)

Common conditions associated with Ear buzzing:

Depression: 3,635 reports
Antidepressant therapy: 3,623 reports
Hypertension: 2,663 reports
High blood pressure: 2,652 reports
Rheumatoid arthritis: 1,927 reports
Anxiety aggravated: 1,913 reports
Feeling uptight: 1,912 reports
Pain: 1,795 reports
Alternative medicine - pain relief: 1,778 reports
Ldl/hdl ratio increased: 1,671 reports

Browse all the conditions that are associated with Ear buzzing:

Ear buzzing (3,083 conditions)

Related publications that referenced our studies

O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .
O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on imatinib mesylate (the active ingredients of Gleevec) and Gleevec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.